In 2023, Oprah Winfrey revealed that she was taking GLP-1 weight loss medication, telling PEOPLE the drugs were "a gift" But just months after starting GLP-1s, Winfrey stopped taking the injections ...
The icon, who has cowritten a new book on obesity, tells PEOPLE she 'tried to beat the medication' Jamie Green In 2023, Oprah Winfrey revealed that she was taking GLP-1 weight loss medication, telling ...
KIRKLAND, Wash, Dec. 19, 2025 /PRNewswire/ -- A new survey from Sunlight.com finds that interest in GLP-1 medications is rising as Americans set weight-loss goals for 2026. The December 2025 survey of ...
Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. Doctors performing certain medical scans on ...
The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity. The disease now affects more than 1 billion people worldwide and is tied to 3.7 ...
After a fast start and viral nicknames, quarterback Jaxson Dart now aims for progress as the struggling Giants face a tough test vs New England. Sports journalist who grew up in Dallas, TX. Lover of ...
Having a baby isn't all cuddles and coos. The postpartum period is marked by sleepless nights, upturned schedules, hormone shifts – and sometimes severe depression and anxiety. Adding to all that is ...
Baldur's Gate Baldur's Gate 3 lead writer says AI-generated writing is a "3/10 at best" and "doesn't" actually help game development RPGs Baldur's Gate 3 director u-turns on the use of AI art in ...
Did you hear about Serena Williams? She just came out!” I had arranged to speak with a woman I’ll call Katherine, 37, a wardrobe stylist in St. Louis, who takes Zepbound to help manage symptoms of ...
Illustration courtesy of Vivian Chang This 3-part series looks at the current evidence for the treatment of SUDs. Part 3 reviews the use of GLP-1 receptor agonists and tobacco use. A variety of ...
Illustration courtesy of Vivian Chang GLP-1 receptor agonists are being studied as a treatment for a variety of substance use disorders (SUDs). This 3-part series looks at the current evidence for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback